Mazzariello Gina (CIK 1913765) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-20). Recent activity: Buy AMLX (21,284 shares), Sell AMLX (15,000 shares), Sell AMLX (15,000 shares), Buy AMLX (74,660 shares), Sell AMLX (6,844 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Buy | 21,284 | $0 |
| 2026-07-13 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 15,000 | $274,746 |
| 2026-07-13 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 15,000 | $264,122 |
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Buy | 74,660 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 6,844 | $99,375 |
| 2026-02-25 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 3,419 | $48,345 |
| 2026-02-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 3,448 | $50,513 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 8,828 | $128,712 |
| 2025-08-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 15,000 | $121,050 |
| 2025-08-14 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 15,000 | $125,100 |
| 2025-05-27 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 1,000 | $0 |
| 2025-04-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 9,192 | $31,988 |
| 2025-03-10 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Buy | 63,851 | $0 |
| 2025-03-05 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Legal Officer | Sell | 1,611 | $5,026 |
Source: SEC Form 4 filings · as of 2026-08-20